Lymphoproliferative Disorders in Primary Immunodeficiencies
Lymphoproliferative Disorders in Primary Immunodeficiencies
批准号:
7752861
负责人:
John Michael Routes
金额:
$31.44万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-01-01 至 2012-12-31
关键词:
B-Cell LymphomasB-Cell NonHodgkins LymphomaBiopsyBone MarrowCancer EtiologyCellular ImmunityChronic Active HepatitisCommon Variable ImmunodeficiencyCytokine GeneDNA SequenceDefectDevelopmentEtiologyFamily memberGenetic PolymorphismGrantGranulomatousHIV-1HerpesviridaeHouseholdHumanHuman GenomeIL10 geneImmune systemImmunologic Deficiency SyndromesImmunosuppressionInfectionInflammatoryInterleukin-6Interstitial Lung DiseasesLinkLiverLiver diseasesLungLung diseasesLymph Node TissueLymphocyteLymphoproliferative DisordersMalignant - descriptorMalignant NeoplasmsMolecularMorbidity - disease rateMutationOpen Reading FramesPatientsPhylogenyPrevalenceProductionRiskRoleSourceStagingSusceptibility GeneViruscohortcytokinehigh risklatent nuclear antigenliver biopsylymph nodesmortalitypathogenpromoter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We demonstrated that patients with common variable immunodeficiency (CVID) and granulomatous and lymphocytic interstitial lung disease (GLILD) are at high risk for the development of B cell lymphomas and early mortality. We also found that a majority of patients with CVID and GLILD (CVID-GLILD) were infected with human herpes virus type 8 (HHV8). In Aim 1, we will determine the prevalence of HHV8 infection in patients with a larger cohort of patients with CVID and broad spectrum of primary immunodeficiencies. To identify the source of HHV8, we will determine the prevalence of HHV8 infection in family members and household contacts of infected and uninfected patients with CVID and determine the molecular phylogeny of HHV8 in infected cohorts by amplifying the highly polymorphic HHV8 K1 ORF by PCR and performing DNA sequencing of the K1 amplicon. In Aim 2, we will expand our observations on the role of HHV8 infection in lymphoproliferative disorders, lung and liver disease in patients with CVID by examining lung, liver or lymph node tissue biopsies for evidence of HHV8 infection. In Aim 3, we will determine if abnormalities in cellular immunity identify patients with CVID at risk for infection with HHV8 and determine if specific promoter polymorphisms in the IL- 6, TNF-1 or IL-10 genes or mutations in the TACI gene predispose patients with CVID to infection with HHV8.
Aim 1: Ascertain the molecular phylogeny of HHV8 in CVID patients infected with HHV8 and determine if HHV8 is an opportunistic pathogen in a larger cohort of patients with CVID and other primary immunodeficiencies.
Aim 2: Ascertain the role of HHV8 infection in the etiology of lung disease, liver disease, lymphoproliferative disorders in patients with CVID.
Aim 3: Determine if promoter polymorphisms of cytokine genes, dysregulated inflammatory cytokine production, and defects in cellular immunity or mutations in the TACI gene predispose patients with CVID to infection with HHV8.Project Narrative
People with impaired immune systems (primary immunodeficiency) have an increased risk of developing and dying from cancer. In this application, we will try to determine the cause of the cancer that occurs in patients with primary immunodeficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoantibody production and regulatory T cells
-
批准号:8513699
-
项目类别:
-
资助金额:$37.83万
-
财政年份:2012
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7845313
-
项目类别:
-
资助金额:$2.2万
-
财政年份:2009
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:8206706
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:8011454
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:7546580
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Lymphoproliferative Disorders in Primary Immunodeficiencies
-
批准号:7371737
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2008
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7669150
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:8113471
-
项目类别:
-
资助金额:$27.92万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7901489
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7316412
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
Anti-tumorigenic Activity of Adenovirus E1A
-
批准号:7484229
-
项目类别:
-
资助金额:$28.79万
-
财政年份:2007
-
负责人:John Michael Routes
-
依托单位:
AMID in Apoptosis and p53-Mediated Downstream Effects
-
批准号:6922103
-
项目类别:
-
资助金额:$27.97万
-
财政年份:2004
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:2693728
-
项目类别:
-
资助金额:$22.5万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6376598
-
项目类别:
-
资助金额:$24.58万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6172911
-
项目类别:
-
资助金额:$23.87万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:2896278
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
DISSIMILAR IMMUNOGENICITIES OF ELA AND E7 ONCOPROTEINS
-
批准号:6513329
-
项目类别:
-
资助金额:$25.32万
-
财政年份:1998
-
负责人:John Michael Routes
-
依托单位:
EXAMINING HELICOBACTER PYLORI GASTRIC INFECTION IN PATIENTS WITH IMMUNODEFICENNCY
-
批准号:6245266
-
项目类别:
-
资助金额:$2.65万
-
财政年份:1997
-
负责人:John Michael Routes
-
依托单位:
VIRAL ONCOGENES, INTERFERON, AND IMMUNITY
-
批准号:2067045
-
项目类别:
-
资助金额:$9.79万
-
财政年份:1992
-
负责人:John Michael Routes
-
依托单位:
VIRAL ONCOGENES, INTERFERON, AND IMMUNITY
-
批准号:3456029
-
项目类别:
-
资助金额:$9.69万
-
财政年份:1992
-
负责人:John Michael Routes
-
依托单位: